Overcoming the Limits of Immunotherapies
08/05/2024
Dr. Karl Petri is establishing a research group at the University Hospital Würzburg to develop and enhance novel CRISPR 2.0 tools for generating and improving cancer-targeted CAR-T cell products.
more